- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06156007
Effect of Progressive Muscle Relaxation Exercises in Menopausal Women Experiencing RLS.
December 11, 2023 updated by: Pinar Akbas, Gazi University
Effect of Progressive Muscle Relaxation Exercise on RLS Severity, Quality of Life and Sleep Quality in Menopausal Women With Restless Legs Syndrome (RLS): A Randomized Controlled Study
Restless legs syndrome is a symptom that can be seen in all stages of a woman's life, but its frequency and severity increases with menopause.
Restless legs syndrome is a neurological problem that occurs usually at night with an irresistible urge to move the legs.
It is a progressive muscle relaxation exercise.
Progressive muscle relaxation exercise is a systematic practice aimed at providing deep relaxation by exercising large muscle groups in the body along with breathing techniques.
This study aims to evaluate the effect of progressive muscle relaxation exercise on the severity of restless legs syndrome, quality of life and sleep quality related to restless legs syndrome in menopausal women with restless legs syndrome.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Menopause, which is a natural part of women's life; It is a condition that occurs between the ages of 45-52 on average and is characterized by hormonal changes and cessation of the menstrual cycle.
Many symptoms are observed during menopause, such as hot flashes, sleep problems, mood disorders, sexual dysfunction, weight gain, and decline in cognitive functioning.
Restless legs syndrome is another symptom that can be seen in all periods of a woman's life, but its frequency and severity increases with menopause.
Restless legs syndrome is a neurological problem that occurs usually at night with an irresistible urge to move the legs.
There are studies reporting that sleep problems, which are a common problem during the menopausal period, worsen with the addition of restless legs syndrome.
Restless legs syndrome and sleep problems are two important factors that negatively affect the quality of life of women in the menopausal period.
Alternative and complementary therapies are frequently used among the methods used to cope with menopausal symptoms and symptoms triggered by menopause.
These methods include hypnosis, body-mind techniques, cognitive behavioral therapies, aromatherapies, and herbal supplements.
It is stated that these techniques reduce the stress of women in the menopausal period and are effective in improving their quality of life.
One of these methods is progressive muscle relaxation exercise.
Progressive muscle relaxation exercise is a systematic practice that aims to provide deep relaxation by exercising large muscle groups in the body along with breathing techniques.
There are studies reporting that PCGE is used effectively in coping with menopausal symptoms.
This study aims to evaluate the effect of progressive muscle relaxation exercise on the severity of restless legs syndrome, quality of life and sleep quality related to restless legs syndrome in menopausal women with restless legs syndrome.
Study Type
Interventional
Enrollment (Estimated)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Pınar AKBAŞ, PhD
- Phone Number: 05051279014
- Email: pnar.ates74@gmail.com
Study Locations
-
-
-
Karabük, Turkey, 78050
- Recruiting
- Karabük Training and Research Hospital
-
Contact:
- Engin yurtçu
-
Principal Investigator:
- Sultan ÖZKAN ŞAT, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Having entered natural menopause
- At least 1 year has passed since the last menstrual period
- Not having any psychiatric disease
- Not having any communication problems (mental, auditory, visual, etc.)
Exclusion Criteria:
- Women not performing post-test applications
- Not doing progressive muscle relaxation exercises twice in a row.
- Wants to quit the research.
- The woman is hospitalized
- Inability to reach women during follow-ups
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: progressive muscle relaxation exercises
Women will be given one-time progressive muscle relaxation exercise training prepared by the researcher.
In the training, the exercise will be demonstrated through demonstration method.
Following training, women will be asked to perform progressive relaxation exercise at least 3 times a week (every other day).
Women will be followed for 8 weeks with a progressive muscle relaxation exercise daily follow-up chart prepared by the researcher, and weekly reminders will be made (via WhatsApp® or text message).
The final test will be administered to women online at the end of 8 weeks.
RLS Severity Rating Scale form, Johns Hopkins Restless Legs Syndrome Quality of Life Scale and Pittsburg Sleep Quality Index will be used in the pre-test and post-test applications.
|
Progressive muscle relaxation exercises (PKGE); 16 large muscles (right hand and forearm, right upper arm, left hand and forearm of left arm, left upper arm, forehead, upper cheek and nose, chin, neck, abdomen, upper right arm, which people can do on their own after learning) leg, right calf, right foot, left upper leg, left thigh and left foot), followed by the contraction and then relaxation and accompanied by deep breathing, is a preferred method for reducing pain, anxiety and depression in individuals.The relaxation will be required to take 10-20 before stretching the next muscle group.
In this way, the muscle groups in the hands, arms, neck, shoulder, chest, abdomen, hips, feet and fingers, face and the whole body will be voluntarily stretched and relaxed, and pregnant women will be relieved.
|
No Intervention: no intervention
No intervention will be applied to women.
Posttest application to women; It will be conducted online 8 weeks after the pre-test application.
RLS Severity Rating Scale form, Johns Hopkins Restless Legs Syndrome Quality of Life Scale and Pittsburg Sleep Quality Index will be used in the pre-test and post-test applications.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Restless Legs Syndrome Severity
Time Frame: Change from Baseline RLS Severity at 8 weeks
|
Measurements will be made using the RLS Severity Rating Scale.
A total score is obtained, with the entire score range varying between 0 and 40; A score between 1-10 indicates mild disease, a score between 11-20 indicates moderate disease, a score between 21-30 indicates severe disease, and a score between 31-40 indicates very severe disease.
|
Change from Baseline RLS Severity at 8 weeks
|
Quality of sleep associated with restless legs syndrome
Time Frame: Change from Baseline Quality of Life at 8 weeks
|
Measurements will be made using the Pittsburg Sleep Quality Index.A high total score indicates poor sleep quality.
Total score is between 0-21.
The index does not indicate the presence or frequency of sleep disturbances.
However, a PSQI total score of 5 or above indicates poor sleep quality.
The cut-off score indicating poor sleep quality is accepted as 5.
|
Change from Baseline Quality of Life at 8 weeks
|
Quality of life associated with restless legs syndrome
Time Frame: Change from Baseline Quality of Life at 8 weeks
|
Measurements will be made using the Johns Hopkins Restless Leg Syndrome Quality of Life Scale.
The lowest score from the scale is 0 and the highest score is 100.
As the score obtained from the scale decreases, it indicates that the quality of life associated with restless legs syndrome is poor.
|
Change from Baseline Quality of Life at 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 25, 2023
Primary Completion (Estimated)
May 30, 2024
Study Completion (Estimated)
May 30, 2024
Study Registration Dates
First Submitted
November 26, 2023
First Submitted That Met QC Criteria
November 26, 2023
First Posted (Actual)
December 5, 2023
Study Record Updates
Last Update Posted (Estimated)
December 15, 2023
Last Update Submitted That Met QC Criteria
December 11, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- menopause
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Restless Legs Syndrome
-
Walter Reed National Military Medical CenterWithdrawnEkbom Syndrome | Restless Legs Syndrome, | Restless Legs,United States
-
XenoPort, Inc.CompletedRestless Legs Syndrome (RLS)United States
-
GlaxoSmithKlineCompletedRestless Legs Syndrome | Restless Legs Syndrome (RLS)United States
-
Otsuka Pharmaceutical Co., Ltd.CompletedIdiopathic Restless Legs Syndrome
-
American Regent, Inc.CompletedRestless Legs Syndrome (RLS)United States
-
Astellas Pharma IncCompletedRestless Legs Syndrome (RLS)Japan
-
Otsuka Pharmaceutical Co., Ltd.CompletedIdiopathic Restless Legs SyndromeJapan
-
UCB PharmaCompletedIdiopathic Restless Legs SyndromeGermany
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedIdiopathic Restless Legs SyndromeUnited States, Spain, Finland, Italy, Germany, Sweden, Austria, Netherlands, United Kingdom
-
American Regent, Inc.CompletedRestless Legs Syndrome (RLS)
Clinical Trials on progressive muscle relaxation exercises
-
Ataturk UniversityCompletedStress | Anxiety | Nursing Students | Relaxation ProgramTurkey
-
KTO Karatay UniversityNot yet recruiting
-
Istanbul Medeniyet UniversitySaglik Bilimleri UniversitesiRecruitingSpinal Stenosis LumbarTurkey
-
Halic UniversityCompletedWomen With Low Sexual Satisfaction | Partners of Women With Low Sexual SatisfactionTurkey
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Atlas UniversityCompletedDementia | Caregiver BurdenTurkey
-
Cairo UniversityNot yet recruiting
-
Osmaniye Korkut Ata UniversityCompleted
-
Riphah International UniversityCompletedAnxiety | Pain SyndromePakistan
-
Saglik Bilimleri UniversitesiCompleted